MHRA approves desmoid tumour treatment
The UK medicines regulator continues to expand treatment options for rare conditions through regulated approvals supported by clinical evidence and ...
Tag: MHRA approval
Sebetralstat Revolutionizes HAE Treatment Options
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) approved Sebetralstat (Ekterly) on July 15, 2025, as the first oral ...
Alyftrek Approval: New Hope for Cystic Fibrosis Patients
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Alyftrek, a triple combination medicine for cystic fibrosis, offering new ...
Lazertinib Approval: New Lung Cancer Treatment Option
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved lazertinib for use with amivantamab to treat adults with non-small ...
UK Approves Givinostat for Duchenne Muscular Dystrophy Treatment
In a significant development for patients with Duchenne muscular dystrophy (DMD), the Medicines and Healthcare products Regulatory Agency (MHRA) has ...
MHRA Approves Adapted Nuvaxovid JN.1 COVID-19 Vaccine for UK
With the ongoing fight against COVID-19 in mind, the Medicines and Healthcare products Regulatory Agency (MHRA) has approved ...
Sugemalimab Gains UK Approval for NSCLC
30 October 2024 – In a significant step for cancer treatment, the UK Medicines and Healthcare products Regulatory Agency (MHRA) ...
UK MHRA Approves Donanemab for Early Alzheimer’s Disease
New news in the fight against Alzheimer’s disease. The Medicines and Healthcare products Regulatory Agency has approved the licence for ...
UK Approves Eplontersen for Rare Nerve Disease
Good news, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has approved eplontersen (also known as Wainua) for the ...
Capivasertib Breast Cancer Treatment Approved in UK
In a landmark decision today, the Medicines and Healthcare products Regulatory Agency (MHRA) approved capivasertib (Truqap) for patients with advanced ...